Home > Press > Microfluidics and HORIBA Instruments, Inc. Announce the Formalization of Their Partnership
Abstract:
Microfluidics, a wholly owned subsidiary of Microfluidics International Corporation (OTCBB: MFLU) and HORIBA Instruments, Inc. are pleased to announce that their long standing partnership has been formalized. Previously, the two companies have shared marketing efforts, such as seminars and joint customer presentations. From this point forward, these efforts also will include shared exhibit booths at trade shows and exhibitions, and joint advertising and lead generation.
The two companies will also join forces in their research and development. This will include development of new products as well as enhancements for existing products for the pharmaceutical, biotechnology, food, chemical, coatings and lubricant industries. Not only will the companies collaborate on technical expertise, but they also will share laboratory facilities, office space and other tangible resources.
"The relationship between Microfluidics and HORIBA has always been mutually advantageous, but our customers will be the true beneficiaries of this new partnership," said Dr. Michael C. Pohl, HORIBA's Vice President of Scientific Instruments. "They will receive the combined expertise of both companies through a single contact and we are excited about the synergy these efforts will generate."
This new partnership is a natural development given the complimentary nature of the companies' operations. Microfluidics is a producer and distributor of proprietary high pressure and high performance materials processing equipment that reduces particle size through deagglomeration, dispersion and processing of micro-emulsions. HORIBA is a world leader in producing and distributing proprietary particle size measurement and analysis equipment. Many laboratories of their joint customers already have a Microfluidizer® processor sitting next to a HORIBA particle size analyzer, but as a result of this partnership that equipment is now standard in all HORIBA and Microfluidics laboratories as well.
"HORIBA and Microfluidics have jointly served many customers over the years," noted William Kober, Microfluidics' Vice President of Sales for the Americas. "This formalized and broader partnership enables the two companies to more fully meet our customers' needs and by doing so accelerate our own companies' growth."
For more information, contact Dr. Michael C. Pohl, Vice President, Scientific Marketing, HORIBA Instruments, Inc., 17671 Armstrong Avenue, Irvine CA 92614, 800.446.7422 or 949.250.4811, , or William Kober, Vice President of Sales for the Americas, Microfluidics, 30 Ossipee Road, Newton, MA 02464, 800.370.5452 or 617.969.5452, .
About HORIBA
HORIBA Instruments is a global leader in analytical instrumentation and measurement technology for a diverse range of measurement types, including particle size analysis, elemental analysis, process and environmental monitoring and medical analyzers. Instruments and systems made by the HORIBA Group set high quality and performance standards across a wide variety of fields, providing class-leading equipment for industries including pharmaceuticals, biotechnology, semiconductors, electronics, physical and chemical sciences, and areas such as environmental monitoring and research into clean energy.
####
About Microfluidics
Microfluidics, a wholly owned subsidiary of Microfluidics International Corporation, is a supplier of advanced fluid processing equipment and reaction technology for laboratory, pilot scale and manufacturing applications. The equipment enables the formulation and manufacture of numerous nanomaterials and nanoscale products and produces the most uniform and smallest liquid and suspended solid particles available.
Microfluidics has been a worldwide supplier of Microfluidizer® high shear fluid processing systems to the biotechnology, pharmaceutical, chemical and cosmetics industries since 1984. As a leader in the field, Microfluidics has enabled numerous companies and institutions to formulate, validate and produce licensed drugs for the worldwide healthcare market.
Companies seeking to produce difficult-to-formulate products or to find better methods of bio-processing can take advantage of complimentary sample testing at any of three Microfluidics facilities.
For more information, please click here
Contacts:
HORIBA Instruments, Inc.
Carol A. Madden
800-446-7422 ext. 1133
or 949-242-8495
Marketing Coordinator, Scientific Division
or
HORIBA Instruments, Inc.
Mark Bumiller
800-446-7422
or 508-366-5664
Vice President, Particle Products
or
Gray & Rice Public Relations
Dinah Alobeid
617-367-0100 ext. 127
or
Microfluidics International Corporation
Brian E. LeClair
800.370.5452 ext. 245
or 617-969-5452 ext. 245
Executive Vice President &
Chief Financial Officer
Copyright © Business Wire 2008
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Microfluidics/Nanofluidics
Implantable device shrinks pancreatic tumors: Taming pancreatic cancer with intratumoral immunotherapy April 14th, 2023
Researchers design new inks for 3D-printable wearable bioelectronics: Potential uses include printing electronic tattoos for medical tracking applications August 19th, 2022
Oregon State University research pushes closer to new therapy for pancreatic cancer May 6th, 2022
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||